See veebileht kasutab küpsiseid kasutaja sessiooni andmete hoidmiseks. Veebilehe kasutamisega nõustute ETISe kasutustingimustega. Loe rohkem
Olen nõus

Toomas Neuman

https://www.etis.ee/CV/Toomas_Neuman/est
22.04.1953
55535771
tom@protobios.com

Teenistuskäik

Töökohad ja ametid
2006–...   
Protobios OÜ, Juhtivteadur (1,00)
2006–...   
FibroTx OÜ, Administratiivtöötaja (1,00)
01.06.2008–01.10.2012   
Tallinna Tehnikaülikool, Matemaatika-loodusteaduskond, Integreeritud süsteemide bioloogia keskus, Professor (0,30)
2005–31.05.2008   
Tallinna Tehnikaülikool, Matemaatika-loodusteaduskond, Geenitehnoloogia instituut, Geenitehnoloogia õppetool, erakorraline dotsent (0,75)
01.01.2003–31.12.2006   
CeMines, Inc. CSO, teadusdirektor
01.01.2001–31.12.2002   
Celmed BioSciences, Inc. Programmi direktor
01.01.1996–31.12.2001   
Department of Surgery Cedars-Sinai Medical Center direktor, neurobioloogia teadur
01.01.1991–31.12.1996   
Department of Anatomy and Neurobiology Colorado State University Fort Collins, abiprofessor
01.01.1988–31.12.1990   
Department of Molecular Cell Biology Max Planck Institute of Biophysical Chemistry, Gottingen, Germany, Max Planck'i ühingu stipendiaat
01.01.1987–31.12.1988   
Helsingi Ülikool, teadur
1980–1988   
Keemilise ja Bioloogilise Füüsika Instituut, Vanemteadur (1,00)
1977–1980   
Tallinna Tehnikaülikool, TTÜ Küberneetika Instituut, Teadur (1,00)
1976–1977   
Tartu Ülikool, Bioloogia-geograafiateaduskond, Molekulaar- ja rakubioloogia instituut, Teadur (1,00)
 
 
Haridustee
1976–1983   
Moskva Arengubioloogia Instituut, arengubioloogia, bioloogiateaduste kandidaat/ võrdsustatud teaduste doktor
1971–1976   
Tartu Ülikool, bioloogia (emrüoloogia, tsütoloogia)

Kvalifikatsioon

Teaduskraadid
Toomas Neuman, doktorikraad, 1983, (juh) , Роль циклических нуклэотитов в рэализатций морфогенетических потенций в ранней эмбриогенесе курицы, Moskva Arengubioloogia Instituut.
 
 
Teadustöö põhisuunad
ETIS KLASSIFIKAATOR: 3. Terviseuuringud; 3.1. Biomeditsiin; CERCS KLASSIFIKAATOR: B726 Kliiniline bioloogia ; TÄPSUSTUS: Raku-ja molekulaarbioloogia, põhihuvi geeni ekspressiooni transkriptsiooniline regulatsioon, raku hemostaasi regulatoorsed mehhanismid, haiguste molekulaarsed mehhanismid, areng ja regeneratsioon, k.a. rakuteraapia ja tüvirakud.

Juhendatud väitekirjad

Publikatsioonid

Klass
Aasta
Publikatsioon
 
1.1.
2016
Sadam, H.; Liivas, U.; Kazantseva, A.; Pruunsild, P.; Kazantseva, J.; Timmusk, T.; Neuman, T.; Palm, K. (2016). GLI2 cell-specific activity is controlled at the level of transcription and RNA processing: Consequences to cancer metastasis. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1862 (1), 46−55.10.1016/j.bbadis.2015.10.008.
1.1.
2016
Kazantseva, J.; Ivanov, R.; Gasik, M.; Neuman, T.; Hussainova, I. (2016). Graphene-augmented nanofiber scaffolds demonstrate new features in cells behaviour. Scientific Reports, 6, #30150. DOI: 10.1038/srep30150.
1.1.
2015
Kazantseva, J.; Tints, K.; Neuman, T.; Palm, K. (2015). TAF4 controls differentiation of human neural progenitor cells through hTAF4-TAFH activity. Journal of Molecular Neuroscience, 55 (1), 160−166. DOI: 10.1007/s12031-014-0295-6.
1.1.
2014
Jääger, Kersti; Fatkina, Angelika; Velts, Anna; Orav, Ester; Neuman, Toomas (2014). Variable expression of lineage regulators in differentiated stromal cells indicates distinct mechanisms of differentiation towards common cell fate. Gene, 533 (1), 173−179.10.1016/j.gene.2013.09.094.
1.1.
2013
Kazantseva, J.; Kivil, A.; Tints, K.; Kazantseva, A.; Neuman, T.; Palm, K. (2013). Alternative splicing targeting the hTAF4-TAFH domain of TAF4 represses proliferation and accelerates chondrogenic differentiation of human mesenchymal stem cells. PLoS ONE, 8 (10), e74799. DOI: 10.1371/journal.pone.0074799.
1.1.
2012
Jääger, Kersti; Islam, Saiful; Zajac, Pawel; Linnarsson, Sten; Neuman, Toomas. (2012). RNA-Seq Analysis Reveals Different Dynamics of Differentiation of Human Dermis- and Adipose-Derived Stromal Stem Cells. PLoS ONE, 7(6)−e38833.10.1371/journal.pone.0038833.
1.1.
2011
Jääger K, Neuman T. (2011). Human dermal fibroblasts exhibit delayed adipogenic differentiation compared to mesenchymal stem cells. Stem cells and development, 8, 1327−1336.
1.1.
2009
Kazantseva, A.; Sepp, M.; Kazantseva, J.; Sadam, H.; Pruunsild, P.; Timmusk, T.; Neuman, T.; Palm, K. (2009). N-terminally truncated BAF57 isoforms contribute to the diversity of SWI/SNF complexes in neurons. Journal of Neurochemistry, 109 (3), 807−818. DOI: 10.1111/j.1471-4159.2009.06005.x.
1.2.
2009
Levesque, M.F., Neuman, T., Rezak, M (2009). Therapeutic Microinjection of Autologous Adult Human Neural Stem Cells and Differentiated Neurons for Parkinson`s Disease: Five-Year Post-Operative Outcome. The Open Stem Cell Journal, 1, 20−29.
5.2.
2009
Sadam, Helle; Verev, Helen; Kazantseva, Jekaterina; Neuman, Toomas; Palm, Kaia (2009). Characterization of physical and functional interaction of BRN2 with the subunits of the RNA polymerase II transcriptional Mediator. bHLH transcription factors: EMBO bHLH transcription factors Workshop, London, UK, 7-8 may 2009. Ed. European Molecular Biology Organization. European Molecular Biology Organization, P26.
5.1.
2008
Vinkel, K.; Kivil, A.; Neuman, T.; Palm, K . (2008). Using gene expression profiling to differentiate breast and colon tumors. Cellular Oncology, 30 (2), 163.
5.1.
2007
Neuman, T.; Sadam, H.; Liik, A. (2007). The state of the transcription machinery determines response of dermal fibroblasts from different individuals to retinoic acid and TGFbeta. Journal of Investigative Dermatology, 127, S82.
5.1.
2006
Maloverjan, A.; Kazantseva, A.; Liik, A.; Palm, K.; Neuman, T . (2006). Manipulating transcriptional control of ECM homeostasis: A novel strategy to rejuvenate skin. Journal of Investigative Dermatology, 126, 39.
1.1.
2004
Brunkhorst, A.; Neuman, T.; Hall, A.; Arenas, E.; Bartfai, T.; Hermanson, O.; Metsis, M. (2004). Novel isoforms of the TFIID subunit TAF4 modulate nuclear receptor-mediated transcriptional activity. Biochemical and Biophysical Research Communications, 325 (2), 574−579. DOI: 10.1016/j.bbrc.2004.10.078.
1.1.
2002
Ehtesham, M.; Kabos, P.; Kabosova, A.; Neuman, T.; Black, K. L.; Yu, J. S. (2002). The use of interleukin 12-secreting neural stem cells for the treatment of intracranial glioma. Cancer research, 62 (20), 5657−5663.
1.1.
2002
Kabos, P;, Kabosova, A.; Neuman, T. (2002). Blocking HES1 expression initiates GABAergic differentiation and induces the expression of p21(CIP1/WAF1) in human neural stem cells. Journal of Biological Chemistry, 277 (11), 8763−8766. DOI: 10.1074/jbc.C100758200.
1.1.
2002
Timmusk, T.; Palm, K.; Belluardo, N.; Mudo, G.; Neuman, T. (2002). Dendritic localization of mammalian neuralized mRNA encoding a protein with transcription repression activities. Molecular and Cellular Neuroscience, 20 (4), 649−668. DOI: 10.1006/mcne.2002.1148.
1.1.
2001
Mizuguchi, T.; Kamohara, Y.; Hui, T.; Neuman, T.; Mitaka, T.; Demetriou, A. A.; Rozga, J. (2001). Regulation of c-Met expression in rats with acute hepatic failure. Journal of Surgical Research, 99 (2), 385−396. DOI: 10.1006/jsre.2001.6216.
1.1.
2001
Metsis, M.; Brunkhorst, A.; Neuman, T. (2001). Cell-type-specific expression of the TFIID component TAF(II)135 in the nervous system. Experimental Cell Research, 269 (2), 214−221. DOI: 10.1006/excr.2001.5307.
1.1.
2000
Holland, L. Z.; Schubert, M.; Holland, N. D.; Neuman, T. (2000). Evolutionary conservation of the presumptive neural plate markers AmphiSox1/2/3 and AmphiNeurogenin in the invertebrate chordate amphioxus. Developmental Biology, 226 (1), 18−33.
1.1.
2000
Kamohara, Y.; Sugiyama, N.; Mizuguchi, T.; Inderbitzin, D.; Lilja, H.; Middleton, Y.; Neuman, T.; Demetriou, A. A.; Rozga, J. (2000). Inhibition of signal transducer and activator transcription factor 3 in rats with acute hepatic failure. Biochemical and Biophysical Research Communications, 273 (1), 129−135.
1.1.
2000
Palm, K.; Salin-Nordström, T.; Levesque, M. F.; Neuman, T. (2000). Fetal and adult human CNS stem cells have similar molecular characteristics and developmental potential. Molecular Brain Research, 78, 192−195.
1.1.
1995
Chiaramello, A.; Neuman, K.; Palm, K.; Metsis, M.; Neuman, T. (1995). Helix-loop-helix transcription factors mediate activation and repression of the p75LNGFR gene. Molecular and Cellular Biology, 15 (11), 6036−6044.
1.1.
1995
Reeben, M.; Neuman, T.; Palgi, J.; Palm, K.; Paalme, V.; Saarma, M (1995). Characterization of the rat light neurofilament (nf-l) gene promoter and identification of ngf and camp-responsive regions. Journal of Neuroscience Research, 40 (2), 177−188.
1.1.
1990
Paves, H.; Neuman, T.; Metsis, M.; Saarma, M. (1990). Nerve growth factor-induced rapid reorganization of microfilaments in PC12 cells: possible roles of different second messenger systems. Experimental Cell Research, 186, 218−226.
1.1.
1989
Neuman, T.; Stephens, R.W.; Salonen, E.-M.; Timmusk, T.; Vaheri, A. (1989). Induction of morphological differentiation of human neuroblastoma cells is accompanied by induction of tissue-type plasminogen activator. Journal of Neuroscience Research, 23, 274−281.
1.1.
1988
Paves, H.; Neuman, T.; Metsis, M.; Saarma, M. (1988). Nerve growth factor induces rapid redistribution of F-actin in PC12 cells. FEBS Letters, 235, 141−143.
1.1.
1988
Paves, K.; Neuman, T.; Metsis, M.; Saarma, M. (1988). Nerve growth factor induces rapid redistribution of F-actin in pheochromocytoma PC12 cells. Doklady Akademii Nauk SSSR, 303 (5), 1265−1267.
1.1.
1988
Laasberg, T.; Pihlak, A.; Neuman, T.; Paves, H.; Saarma, M. (1988). Nerve growth factor increases the cyclic GMP level and activates the cyclic GMP phosphodiesterase in PC12 cells. FEBS Letters, 239, 367−370.
1.3.
1984
Neuman, T.; Laasberg, T.; Kärner, J. (1984). [Effect of cyclic nucleotides on the morphogenetic and ultrastructural characteristics of the primitive knot in the chick embryo in organotypic cultures]. Ontogenez (Moscow), 88−91.
2.2.
1984
Tiivel, T.; Kull, K.; Neuman, T.; Sutrop, U. (eds) (1984). Theory and Models in Life Science. . . Tartu: Tartu Ülikool.
1.1.
1983
Neuman, T.; Laasberg, T.; Karner, J. (1983). Ultrastructural-localization of adenylate-cyclase and camp phosphodiesterase in the gastrulating chick-embryo. Wilhelm Rouxs Archives of Developmental Biology, 192 (1), 42−44.
3.5.
1983
Kärner, J.; Neuman, T.; Raid, R. (1983). Ultrastructural localization of adenylate cyclase during early embryogenesis. Modern methods in electron microscopy. Tallinn, 74−75.

Tööstusomand

17.07.2020

Toomas Neuman

https://www.etis.ee/CV/Toomas_Neuman/eng
22.04.1953
55535771
tom@protobios.com

Career

Institutions and positions
2006–...   
Protobios LLC, Chief Scientific Officer (1,00)
2006–...   
FibroTx, Member of the Management Board (1,00)
01.06.2008–01.10.2012   
Tallinn University of Technology , Faculty of Science, Centre for Biology of Integrated Systems, Professor (0,30)
2005–31.05.2008   
Tallinn University of Technology , Faculty of Science, Department of Gene Technology, Chair of Gene Technology, Extraordinary Associate Professor (0,75)
01.01.2003–31.12.2006   
CeMines, Inc. CSO, Chief Science Officer
01.01.2001–31.12.2002   
Celmed BioSciences, Inc. Program Director
01.01.1996–31.12.2001   
Department of Surgery Cedars-Sinai Medical Center Director, Neurobiology Research Scientist II
01.01.1991–31.12.1996   
Department of Anatomy and Neurobiology Colorado State University Fort Collins, CO, U S A Assistant Professor
01.01.1988–31.12.1990   
Department of Molecular Cell Biology Max Planck Institute of Biophysical Chemistry, Gottingen, Germany Max-Planck society fellowship
01.01.1987–31.12.1988   
Department of Virology University of Helsinki, Helsinki, Finland Visiting Scientist
1980–1988   
National Institute of Chemical Physics and Biophysics, Senior Researcher (1,00)
1977–1980   
Tallinn University of Technology , Institute of Cybernetics at TUT, Researcher (1,00)
1976–1977   
University of Tartu, Faculty of Biology and Geography, Institute of Molecular and Cell Biology, Researcher (1,00)
 
 
Education
1976–1983   
Institute of Developmental Biology, Moscow, USSR Developmental Biology Ph. D.
1971–1976   
Tartu State University Tartu, Estonia Biology (embryology,cytology)

Qualifications

Academic degrees
Toomas Neuman, Doctor's Degree, 1983, (sup) , Роль циклических нуклэотитов в рэализатций морфогенетических потенций в ранней эмбриогенесе курицы, Moskva Arengubioloogia Instituut.
 
 
Fields of research
ETIS CLASSIFICATION: 3. Health; 3.1. Biomedicine; CERCS CLASSIFICATION: B726 Clinical biology ; SPECIFICATION: My research centers on the cell and molecular biology. My main interests are focused on transcriptional regulation of gene expression, regulatory mechanisms of cell homeostasis and homeoresis, molecular mechanisms of diseases, mechanisms of development and regeneration, cell therapy and stem cells.
 
 

Supervised dissertations

Publications

Category
Year
Publication
 
1.1.
2016
Sadam, H.; Liivas, U.; Kazantseva, A.; Pruunsild, P.; Kazantseva, J.; Timmusk, T.; Neuman, T.; Palm, K. (2016). GLI2 cell-specific activity is controlled at the level of transcription and RNA processing: Consequences to cancer metastasis. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1862 (1), 46−55.10.1016/j.bbadis.2015.10.008.
1.1.
2016
Kazantseva, J.; Ivanov, R.; Gasik, M.; Neuman, T.; Hussainova, I. (2016). Graphene-augmented nanofiber scaffolds demonstrate new features in cells behaviour. Scientific Reports, 6, #30150. DOI: 10.1038/srep30150.
1.1.
2015
Kazantseva, J.; Tints, K.; Neuman, T.; Palm, K. (2015). TAF4 controls differentiation of human neural progenitor cells through hTAF4-TAFH activity. Journal of Molecular Neuroscience, 55 (1), 160−166. DOI: 10.1007/s12031-014-0295-6.
1.1.
2014
Jääger, Kersti; Fatkina, Angelika; Velts, Anna; Orav, Ester; Neuman, Toomas (2014). Variable expression of lineage regulators in differentiated stromal cells indicates distinct mechanisms of differentiation towards common cell fate. Gene, 533 (1), 173−179.10.1016/j.gene.2013.09.094.
1.1.
2013
Kazantseva, J.; Kivil, A.; Tints, K.; Kazantseva, A.; Neuman, T.; Palm, K. (2013). Alternative splicing targeting the hTAF4-TAFH domain of TAF4 represses proliferation and accelerates chondrogenic differentiation of human mesenchymal stem cells. PLoS ONE, 8 (10), e74799. DOI: 10.1371/journal.pone.0074799.
1.1.
2012
Jääger, Kersti; Islam, Saiful; Zajac, Pawel; Linnarsson, Sten; Neuman, Toomas. (2012). RNA-Seq Analysis Reveals Different Dynamics of Differentiation of Human Dermis- and Adipose-Derived Stromal Stem Cells. PLoS ONE, 7(6)−e38833.10.1371/journal.pone.0038833.
1.1.
2011
Jääger K, Neuman T. (2011). Human dermal fibroblasts exhibit delayed adipogenic differentiation compared to mesenchymal stem cells. Stem cells and development, 8, 1327−1336.
1.1.
2009
Kazantseva, A.; Sepp, M.; Kazantseva, J.; Sadam, H.; Pruunsild, P.; Timmusk, T.; Neuman, T.; Palm, K. (2009). N-terminally truncated BAF57 isoforms contribute to the diversity of SWI/SNF complexes in neurons. Journal of Neurochemistry, 109 (3), 807−818. DOI: 10.1111/j.1471-4159.2009.06005.x.
1.2.
2009
Levesque, M.F., Neuman, T., Rezak, M (2009). Therapeutic Microinjection of Autologous Adult Human Neural Stem Cells and Differentiated Neurons for Parkinson`s Disease: Five-Year Post-Operative Outcome. The Open Stem Cell Journal, 1, 20−29.
5.2.
2009
Sadam, Helle; Verev, Helen; Kazantseva, Jekaterina; Neuman, Toomas; Palm, Kaia (2009). Characterization of physical and functional interaction of BRN2 with the subunits of the RNA polymerase II transcriptional Mediator. bHLH transcription factors: EMBO bHLH transcription factors Workshop, London, UK, 7-8 may 2009. Ed. European Molecular Biology Organization. European Molecular Biology Organization, P26.
5.1.
2008
Vinkel, K.; Kivil, A.; Neuman, T.; Palm, K . (2008). Using gene expression profiling to differentiate breast and colon tumors. Cellular Oncology, 30 (2), 163.
5.1.
2007
Neuman, T.; Sadam, H.; Liik, A. (2007). The state of the transcription machinery determines response of dermal fibroblasts from different individuals to retinoic acid and TGFbeta. Journal of Investigative Dermatology, 127, S82.
5.1.
2006
Maloverjan, A.; Kazantseva, A.; Liik, A.; Palm, K.; Neuman, T . (2006). Manipulating transcriptional control of ECM homeostasis: A novel strategy to rejuvenate skin. Journal of Investigative Dermatology, 126, 39.
1.1.
2004
Brunkhorst, A.; Neuman, T.; Hall, A.; Arenas, E.; Bartfai, T.; Hermanson, O.; Metsis, M. (2004). Novel isoforms of the TFIID subunit TAF4 modulate nuclear receptor-mediated transcriptional activity. Biochemical and Biophysical Research Communications, 325 (2), 574−579. DOI: 10.1016/j.bbrc.2004.10.078.
1.1.
2002
Ehtesham, M.; Kabos, P.; Kabosova, A.; Neuman, T.; Black, K. L.; Yu, J. S. (2002). The use of interleukin 12-secreting neural stem cells for the treatment of intracranial glioma. Cancer research, 62 (20), 5657−5663.
1.1.
2002
Kabos, P;, Kabosova, A.; Neuman, T. (2002). Blocking HES1 expression initiates GABAergic differentiation and induces the expression of p21(CIP1/WAF1) in human neural stem cells. Journal of Biological Chemistry, 277 (11), 8763−8766. DOI: 10.1074/jbc.C100758200.
1.1.
2002
Timmusk, T.; Palm, K.; Belluardo, N.; Mudo, G.; Neuman, T. (2002). Dendritic localization of mammalian neuralized mRNA encoding a protein with transcription repression activities. Molecular and Cellular Neuroscience, 20 (4), 649−668. DOI: 10.1006/mcne.2002.1148.
1.1.
2001
Mizuguchi, T.; Kamohara, Y.; Hui, T.; Neuman, T.; Mitaka, T.; Demetriou, A. A.; Rozga, J. (2001). Regulation of c-Met expression in rats with acute hepatic failure. Journal of Surgical Research, 99 (2), 385−396. DOI: 10.1006/jsre.2001.6216.
1.1.
2001
Metsis, M.; Brunkhorst, A.; Neuman, T. (2001). Cell-type-specific expression of the TFIID component TAF(II)135 in the nervous system. Experimental Cell Research, 269 (2), 214−221. DOI: 10.1006/excr.2001.5307.
1.1.
2000
Holland, L. Z.; Schubert, M.; Holland, N. D.; Neuman, T. (2000). Evolutionary conservation of the presumptive neural plate markers AmphiSox1/2/3 and AmphiNeurogenin in the invertebrate chordate amphioxus. Developmental Biology, 226 (1), 18−33.
1.1.
2000
Kamohara, Y.; Sugiyama, N.; Mizuguchi, T.; Inderbitzin, D.; Lilja, H.; Middleton, Y.; Neuman, T.; Demetriou, A. A.; Rozga, J. (2000). Inhibition of signal transducer and activator transcription factor 3 in rats with acute hepatic failure. Biochemical and Biophysical Research Communications, 273 (1), 129−135.
1.1.
2000
Palm, K.; Salin-Nordström, T.; Levesque, M. F.; Neuman, T. (2000). Fetal and adult human CNS stem cells have similar molecular characteristics and developmental potential. Molecular Brain Research, 78, 192−195.
1.1.
1995
Chiaramello, A.; Neuman, K.; Palm, K.; Metsis, M.; Neuman, T. (1995). Helix-loop-helix transcription factors mediate activation and repression of the p75LNGFR gene. Molecular and Cellular Biology, 15 (11), 6036−6044.
1.1.
1995
Reeben, M.; Neuman, T.; Palgi, J.; Palm, K.; Paalme, V.; Saarma, M (1995). Characterization of the rat light neurofilament (nf-l) gene promoter and identification of ngf and camp-responsive regions. Journal of Neuroscience Research, 40 (2), 177−188.
1.1.
1990
Paves, H.; Neuman, T.; Metsis, M.; Saarma, M. (1990). Nerve growth factor-induced rapid reorganization of microfilaments in PC12 cells: possible roles of different second messenger systems. Experimental Cell Research, 186, 218−226.
1.1.
1989
Neuman, T.; Stephens, R.W.; Salonen, E.-M.; Timmusk, T.; Vaheri, A. (1989). Induction of morphological differentiation of human neuroblastoma cells is accompanied by induction of tissue-type plasminogen activator. Journal of Neuroscience Research, 23, 274−281.
1.1.
1988
Paves, H.; Neuman, T.; Metsis, M.; Saarma, M. (1988). Nerve growth factor induces rapid redistribution of F-actin in PC12 cells. FEBS Letters, 235, 141−143.
1.1.
1988
Paves, K.; Neuman, T.; Metsis, M.; Saarma, M. (1988). Nerve growth factor induces rapid redistribution of F-actin in pheochromocytoma PC12 cells. Doklady Akademii Nauk SSSR, 303 (5), 1265−1267.
1.1.
1988
Laasberg, T.; Pihlak, A.; Neuman, T.; Paves, H.; Saarma, M. (1988). Nerve growth factor increases the cyclic GMP level and activates the cyclic GMP phosphodiesterase in PC12 cells. FEBS Letters, 239, 367−370.
1.3.
1984
Neuman, T.; Laasberg, T.; Kärner, J. (1984). [Effect of cyclic nucleotides on the morphogenetic and ultrastructural characteristics of the primitive knot in the chick embryo in organotypic cultures]. Ontogenez (Moscow), 88−91.
2.2.
1984
Tiivel, T.; Kull, K.; Neuman, T.; Sutrop, U. (eds) (1984). Theory and Models in Life Science. . . Tartu: Tartu Ülikool.
1.1.
1983
Neuman, T.; Laasberg, T.; Karner, J. (1983). Ultrastructural-localization of adenylate-cyclase and camp phosphodiesterase in the gastrulating chick-embryo. Wilhelm Rouxs Archives of Developmental Biology, 192 (1), 42−44.
3.5.
1983
Kärner, J.; Neuman, T.; Raid, R. (1983). Ultrastructural localization of adenylate cyclase during early embryogenesis. Modern methods in electron microscopy. Tallinn, 74−75.

Industrial property

17.07.2020

Otsi projekti

  • {{item.Name}}
Asutus on projekti finantseerija   Asutus on projekti teostaja  
  • {{searchListItem.Name}}
Kõik   Tavaprojektid   Ülemprojektid   Alamprojektid  
Uus Frascati (2015)
Uus ja vana Frascati (otsing uue järgi väljastab ka seotud vanad)
Kõik
Käimasolevad
Lõppenud
Algus
Hajus
Täpne
Lihtotsing Tühjenda
  • Leitud 10 kirjet
ProgrammLiikNumberNimiProjekti algusProjekti lõppVastutav täitjaAsutusFinantseerijapoolne rahastamine
MUUEU612308Academic Industry R&D Opportunities for Picornaviruses01.10.201430.09.2019Kaia PalmProtobios OÜ232 321,00 EUR
1.2.2.1.COST BM1406 (BMBS COST Action BM1406)Ion Channels and Immune Response toward a global understanding of immune cell physiology and for new therapeutic approaches (IONCHAN-IMMUNRESPON)14.11.201430.03.2019Kaia PalmProtobios OÜ30 000,00 EUR
MUUEU 27552Keskonnaseire metagenoomse platvormi arendus15.09.200731.08.2010Madis MetsisBiotaTec OÜ444 202,00 EUR
MUUEU 27376Keskonnaseire metagenoomse platvormi arendus16.07.200715.08.2007Madis MetsisBiotaTec OÜ12 725,00 EUR
MUUEU602694Local immunomodulation around implants by innovative auxiliary hydrogel-based systems encapsulating autologous and phenotype controlled macrophages 01.10.201330.09.2017Kaia PalmProtobios OÜ619 942,00 EUR
MUUEU 29922Mikrobioomide analüüs10.01.200909.04.2009Liina EekBiotaTec OÜ18 406,00 EUR
MUUEU27549Peptiidsete ravimikandidaatide rakendusuuring01.01.200831.12.2009Kaia PalmProtobios OÜ317 909,32 EUR
MUUEU21276Rakendusuuring rakuteraapia tehnoloogia ja rakukiipide väljatöötamiseks01.08.200531.12.2007Kaia PalmProtobios OÜ530 339,82 EUR
MUUIN5022Välisõppejõudude-teadlaste ja järeldoktorite toomine Tallinna Tehnikaülikooli geenitehnoloogia instituuti geenitehnoloogia kui teadus- ja majandusharu edasiarendamiseks02.07.200530.06.2007Erkki TruveTallinna Tehnikaülikool; Tallinna Tehnikaülikool, Matemaatika-loodusteaduskond, Geenitehnoloogia instituut222 721,10 EUR
MUUEU675746‘Immunoprofile-directed stratification of patients with the autoimmune disorder thrombotic thrombocytopenic purpura’ 01.04.201528.02.2019Kaia PalmProtobios OÜ90 000,00 EUR